Methods of inhibiting cytochrome P450 2D6 enzymes are provided that can be usedfor improving the treatment of diseases by preventing degradation of drugs orother molecules by cytochrome P450 2D6. Pharmaceutical compositions are providedthat can act as boosters to improve the pharmacokinetics, enhance the bioavailability,and enhance the therapeutic effect of drugs that undergo